Perimenopause & Menopause: Navigating Hormone Changes

Menopause is defined as 12 consecutive months without a menstrual period and typically occurs between ages 45 and 55, with an average age of 51.

Perimenopause is the transition period leading up to menopause — often beginning in the early-to-mid 40s but sometimes as early as the mid-30s. During perimenopause, estrogen and progesterone levels fluctuate erratically before ultimately declining. This erratic phase is often when symptoms are most intense.

Postmenopause refers to the years after menopause. Symptoms can persist for a decade or more, and risks associated with estrogen deficiency — including osteoporosis and cardiovascular disease — become more significant.

Many women are surprised to find that their symptoms begin years before their last period. Irregular cycles, worsening PMS, sleep disruption, and mood changes in your early 40s can all be signs of perimenopausal hormone shifts.

Hormonal changes during perimenopause and menopause affect virtually every system in the body. The most commonly reported symptoms include:

Vasomotor symptoms: Hot flashes and night sweats affect approximately 75–85% of women and are caused by estrogen's role in thermoregulation. They can disrupt sleep and persist for 7–10 years on average.

Sleep disruption: Progesterone has sedating, anxiolytic effects. As it declines, many women develop insomnia, difficulty staying asleep, or non-restorative sleep.

Mood and cognition: Estrogen influences serotonin, dopamine, and GABA systems. Declining estrogen is associated with increased anxiety, depression, irritability, and brain fog.

Weight and body composition: Hormonal changes alter fat distribution (more visceral fat) and reduce metabolic rate and muscle mass — making weight gain common even without lifestyle changes.

Bone density: Estrogen is critical for bone maintenance. Bone loss accelerates dramatically in the first 5–7 years after menopause.

Genitourinary symptoms: Vaginal dryness, discomfort during intercourse, and urinary urgency or frequency (collectively called genitourinary syndrome of menopause, or GSM) affect over half of postmenopausal women.

Sexual function: Reduced libido, slower arousal, and discomfort during sex are common and often addressable with hormonal and non-hormonal interventions.

Bioidentical hormones are chemically identical in structure to the hormones your body produces. They differ from older synthetic hormone formulations (like Premarin and Provera) that were used in large studies in the 1990s and 2000s.

The fear around HRT largely stems from a misinterpretation of the Women's Health Initiative (WHI) study, which used synthetic conjugated equine estrogen with synthetic progestin in older postmenopausal women (average age 63). Subsequent reanalysis has shown that for women who initiate hormone therapy within 10 years of menopause (the 'timing hypothesis'), the benefit-risk profile is very different.

Modern bioidentical hormone therapy options for women include:

Estradiol — The primary estrogen produced before menopause. Available as patches, gels, creams, or pellets. Systemic estradiol addresses hot flashes, sleep, mood, cognition, and bone density.

Progesterone — Micronized progesterone (Prometrium) is bioidentical and has a more favorable safety profile than synthetic progestins, with additional benefits for sleep and anxiety.

Testosterone — Often overlooked in women's HRT, low-dose testosterone addresses libido, energy, cognitive clarity, and muscle maintenance. Levels in women are a fraction of male levels but still clinically significant.

DHEA — Intravaginal DHEA (Intrarosa) specifically addresses genitourinary symptoms without significant systemic absorption.

Most healthy women in their 40s and 50s who are symptomatic are candidates for hormone therapy. The decision involves weighing benefits against individual risk factors.

HRT is generally the most effective treatment for hot flashes and night sweats, sleep disruption, genitourinary symptoms, and prevention of bone loss. It also appears to reduce risk of type 2 diabetes and may be cardioprotective when started within 10 years of menopause.

HRT requires more careful consideration — and often modified approaches — in women with a personal history of hormone-sensitive breast cancer, active blood clot history, or certain cardiovascular conditions. This is exactly why a thorough evaluation with a knowledgeable provider matters.

At Peak Medical Wellness, we don't use a cookie-cutter approach. Your protocol is built around your labs, symptoms, health history, and goals — and adjusted over time as your needs evolve.